Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Robotic Surgical Procedures × Thoracic × Clear all

Status

Unknown 2 Active not recruiting 2 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 2 Gynecologic 2 Thoracic 1 Sarcoma 1 Other neoplasm 1 Other 1 Gastrointestinal 1 Endocrine 1

Conditions

Neoadjuvant Chemoimmunotherapy 1

Interventions

Carboplatin 186 pembrolizumab 159 Pemetrexed 134 Cisplatin 101 Drug Therapy 68 Paclitaxel 61 osimertinib 54 Radiotherapy 51 Nivolumab 51 Magnetic Resonance Spectroscopy 49 Specimen Handling 47 durvalumab 46 Docetaxel 45 atezolizumab 43 Etoposide 42 Bevacizumab 39 tislelizumab 34 Blood Specimen Collection 33 Radiosurgery 30 Gemcitabine 27 130-nm albumin-bound paclitaxel 27 Immunotherapy 26 cemiplimab 24 Immune Checkpoint Inhibitors 24 Injections 21 aflutinib 20 Cetuximab 19 Surgical Procedures, Operative 17 Standard of Care 17 Biopsy 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07528066 2026-04-14

DRAGON-NSCLC

Shanghai Chest Hospital

Neoadjuvant Chemoimmunotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡